» Articles » PMID: 38376579

OCT Angiography 2023 Update: Focus on Diabetic Retinopathy

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 2024 Feb 20
PMID 38376579
Authors
Affiliations
Soon will be listed here.
Abstract

Optical coherence tomography angiography (OCTA) has become part of the clinical practice and its growing applications are in continuous development. Coherently with the growing concern about the human and economic cost of diabetes, diabetic retinopathy (DR) was the most popular topic for OCTA studies in the past year. The analysis of the literature reveals that applications of OCTA in DR are in continuous growth. In particular, ultrawide field (UWF) OCTA and artificial intelligence (AI) based on OCTA images are affirming as the new frontiers of scientific research in the field. Diagnostic accuracy of AI methods based on OCTA is equal or superior to the one based on OCT methods and also bears potential to detect systemic associations. UWF OCTA is noninvasive method that is reaching similar accuracy of FA in detection of neovascularization and intraretinal microvascular abnormalities (IRMAs) and has allowed better characterization of microvascular peripherical changes in DR. Lastly, deep capillary plexus (DCP) characteristics seem to play a pivotal role in the development of diabetic macular edema (DME) and refinement of biomarkers for different phenotypes of DME and diabetic macular ischemia (DMI) is currently on its way.

Citing Articles

Long-term functional, anatomical outcome, and qualitative analysis by OCTA, as a predictor of disease recurrences in patients with choroidal neovascularization secondary to angioid streaks.

Velez-Montoya R, Osorio-Landa H, Franco-Ramirez K, Martinez-Pacheco V, Ramirez-Estudillo J, Rosales-Padron J Int J Retina Vitreous. 2024; 10(1):53.

PMID: 39075569 PMC: 11285434. DOI: 10.1186/s40942-024-00568-y.


Advances in Structural and Functional Retinal Imaging and Biomarkers for Early Detection of Diabetic Retinopathy.

Zhang Z, Deng C, Paulus Y Biomedicines. 2024; 12(7).

PMID: 39061979 PMC: 11274328. DOI: 10.3390/biomedicines12071405.

References
1.
Crincoli E, Colantuono D, Zhao Z, Souied E, Miere A . Optical coherence tomography angiography for quantitative microvascular assessment in diabetic retinopathy: inter-device and intra-device agreement and correlation with clinical staging. Acta Diabetol. 2022; 59(9):1219-1227. DOI: 10.1007/s00592-022-01921-z. View

2.
Crincoli E, Colantuono D, Miere A, Zhao Z, Ferrara S, Souied E . Perivenular Capillary Rarefaction in Diabetic Retinopathy: Interdevice Characterization and Association to Clinical Staging. Ophthalmol Sci. 2023; 3(2):100269. PMC: 9978849. DOI: 10.1016/j.xops.2023.100269. View

3.
Sun Z, Tang F, Wong R, Lok J, Szeto S, Chan J . OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema: A Prospective Study. Ophthalmology. 2019; 126(12):1675-1684. DOI: 10.1016/j.ophtha.2019.06.016. View

4.
Kirthi V, Reed K, Alattar K, Zuckerman B, Bunce C, Nderitu P . Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes, challenging the diagnostic threshold of diabetes. Diabet Med. 2022; 40(3):e14952. PMC: 10087038. DOI: 10.1111/dme.14952. View

5.
Yao H, Li Z . Is preclinical diabetic retinopathy in diabetic nephropathy individuals more severe?. Front Endocrinol (Lausanne). 2023; 14:1144257. PMC: 10064084. DOI: 10.3389/fendo.2023.1144257. View